Take control of your IBM licensing. Whether you’re facing an audit, navigating an ELA renewal, optimising PVU costs, or cleaning up sub-capacity compliance — our team of former IBM insiders fights for your bottom line.
We don’t resell IBM licences. We have no IBM affiliation. Every recommendation is built to cut your IBM costs, reduce audit exposure, and give you leverage — not lock-in.
Comprehensive analysis of your IBM software usage, entitlements, and compliance exposure. We review PVU, RVU, user metrics, ILMT data, and virtualisation configurations to uncover shelfware and over-licensing.
We manage every phase of the IBM audit — from initial notification to final settlement. We challenge deployment assumptions, validate ILMT data, and negotiate inflated claims down to real exposure.
Don’t auto-renew your IBM ELA. We evaluate whether to renew, restructure, or exit — with pricing benchmarks, usage analysis, and a clear commercial strategy.
IBM wants growth. We want fairness. We benchmark pricing, challenge bundling, negotiate flexibility clauses, and secure terms that protect your budget across Passport Advantage, ELAs, and cloud agreements.
Align your IBM licence usage with actual business needs. We review PVU configurations, virtualisation settings, Cloud Pak deployments, and sub-capacity reporting to reduce costs without disruption.
IBM’s Cloud Paks and hybrid cloud licensing add new layers of complexity. We assess container licensing, IBM License Service data, and Red Hat entitlements to ensure you’re not over-provisioned.
Let us review your IBM landscape and show you exactly where the risk and savings are — with a no-obligation business case and projected ROI.
Or call us directly: +1 (239) 402-7397
No commitment until you see a business case with projected savings. The entire onboarding process typically takes less than two weeks.
We sign a mutual NDA to protect your confidential information before any data is shared. Standard process, typically same-day.
A confidential call to discuss your IBM landscape, ELA timeline, ILMT status, virtualisation, and audit concerns. No obligation.
Share your Passport Advantage agreements, ELA terms, and ILMT reports. We review everything under NDA and identify every optimisation opportunity.
We deliver a detailed business case showing projected savings, risk reduction, and our fixed advisory fee — so you can see the ROI before you commit.
Once approved, we hit the ground running. Your IBM engagement kicks off immediately with a dedicated team of former IBM licensing specialists.
No commitment. No cost until you see the business case.
We don’t resell IBM. We don’t hold IBM partnerships. We just help you stop overpaying.
No IBM partnerships. No reseller conflicts. Every recommendation is built to protect your budget and your leverage — not IBM’s revenue targets or IASP programme goals.
Our team includes former IBM employees with over 200 years of collective experience. We know how IBM structures deals, runs audits, and prices ELAs — and we know how to counter every tactic.
PVU, RVU, ILMT, sub-capacity, Cloud Paks, Passport Advantage, ELAs, mainframe licensing — we know every IBM licensing model and how to optimise each one for maximum savings.
Real outcomes from real IBM engagements. Every case started with a client facing IBM pressure — and ended with measurable savings.
IBM identified $82M in licensing exposure across mainframe and distributed environments. Our team challenged deployment assumptions and ILMT data, reducing the final settlement to $600K.
Read case study →Optimised IBM mainframe licensing through capacity model restructuring and usage analysis, delivering $71M in savings for one of Japan’s largest financial institutions.
Read case study →Restructured IBM ELA and identified unused product entitlements across global operations, delivering $23M in savings through internal assessment and renegotiation.
Read case study →Comprehensive assessment identified $6M in IBM shelfware and over-licensed PVU deployments, with a remediation roadmap that reduced annual S&S costs by 35%.
Read case study →IBM identified $198.8M in licensing exposure. Our team of former IBM specialists dismantled the claim through ILMT data validation and deployment analysis, avoiding the full exposure.
Read case study →Oracle, Microsoft, SAP, Salesforce, IBM, Broadcom, AWS, and GenAI. Browse 500+ real-world outcomes across 9 vendor practices and 40+ countries.
Browse all case studies →